Jack Geltosky

John Geltosky currently works at The Cancer Prevention & Research Institute of Texas, as Chairman-Product Development Review Council, JEG & Associates LLC, as Managing Director from 2011, Medicenna Therapeutics Corp., as Independent Non-Executive Director from 2020, and Aztec Components, Inc., as Senior Vice President-Business Development.
Dr. Geltosky also formerly worked at Message Pharmaceuticals, Inc., as President & Chief Executive Officer, Enzon Pharmaceuticals, Inc., as Director from 2008 to 2009, Sophiris Bio, Inc., as Independent Director from 2008 to 2020, Bristol Myers Squibb Co., as VP-External Science, Technology & Licensing, GSK Plc, as Vice President-Scientific Licensing, and Arizona Science & Technology Enterprises LLC, as SVP-Business Development & Life Sciences from 2007 to 2011.
Dr. Geltosky received his doctorate degree from California Institute of Technology and undergraduate degree from the University of Memphis.